| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-11-10 | Maersk-Moller Kimberly Chief Commercial Officer | Sale | -58,300 | -19.74%236,982 | $7.42 | $432,329 | View SEC filing | |
| 2025-05-05 | Capper Joseph H Chief Executive Officer | Purchase | +200,000 | +60.69%529,530 | $6.34 | $1,268,000 | View SEC filing | |
| 2025-03-20 | Maersk-Moller Kimberly Chief Commercial Officer | Sale | -1,759 | -0.57%309,077 | $8.04 | $14,142 | View SEC filing | |
| 2025-03-14 | Hulse William Frank IV General Counsel and CAO | Sale | -54,596 | -11.03%440,178 | $7.89 | $430,762 | View SEC filing | |
| 2025-03-14 | Maersk-Moller Kimberly Chief Commercial Officer | Sale | -4,106 | -1.30%310,836 | $7.89 | $32,396 | View SEC filing | |
| 2025-03-12 | Hulse William Frank IV General Counsel and CAO | Sale | -81,446 | -14.13%494,774 | $7.80 | $635,279 | View SEC filing | |
| 2025-03-05 | Maersk-Moller Kimberly Chief Commercial Officer | Sale | -2,111 | -0.79%265,271 | $8.41 | $17,743 | View SEC filing | |
| 2025-02-18 | Whitlow Ricci S Chief Operating Officer | Sale | -61,420 | -13.22%403,019 | $8.28 | $508,558 | View SEC filing | |
| 2024-03-15 | Hulse William Frank IV General Counsel and CAO | Sale | -20,381 | -4.07%479,959 | $7.95 | $162,029 | View SEC filing | |
| 2024-02-21 | Whitlow Ricci S Chief Operating Officer | Sale | -30,764 | -7.12%401,050 | $8.04 | $247,426 | View SEC filing | |
| 2024-02-16 | Whitlow Ricci S Chief Operating Officer | Sale | -31,043 | -6.71%431,814 | $8.05 | $249,763 | View SEC filing | |
| 2023-11-22 | DOUG RICE Chief Financial Officer | Purchase | +5,000 | +5.14%102,200 | $7.16 | $35,787 | View SEC filing | |
| 2023-06-26 | Capper Joseph H Chief Executive Officer | Purchase | +100,000 | +100.00%100,000 | $6.40 | $640,434 | View SEC filing | |
| 2023-05-17 | Stein Robert Benjamin President, Regenerative Med. | Sale | -13,972 | -4.21%317,803 | $6.00 | $83,798 | View SEC filing | |
| 2023-05-12 | Hulse William Frank IV General Counsel and CAO | Sale | -5,870 | -1.27%456,564 | $5.93 | $34,786 | View SEC filing | |
| 2023-05-12 | Stein Robert Benjamin President, Regenerative Med. | Sale | -5,869 | -1.74%331,775 | $5.93 | $34,780 | View SEC filing | |
| 2023-05-12 | Phelan William Lawrence Chief Accounting Officer | Sale | -1,595 | -0.86%184,219 | $5.93 | $9,452 | View SEC filing | |
| 2023-05-12 | Carlson Peter M Chief Financial Officer | Sale | -5,976 | -0.90%656,435 | $5.93 | $35,414 | View SEC filing | |
| 2023-05-09 | Stein Robert Benjamin President, Regenerative Med. | Sale | -51,756 | -13.29%337,644 | $5.34 | $276,470 | View SEC filing | |
| 2023-05-03 | Phelan William Lawrence Chief Accounting Officer | Sale | -5,200 | -2.72%185,814 | $3.80 | $19,739 | View SEC filing | |
| 2023-04-27 | Hulse William Frank IV General Counsel and CAO | Sale | -5,988 | -1.28%462,434 | $3.74 | $22,419 | View SEC filing | |
| 2023-04-27 | Phelan William Lawrence Chief Accounting Officer | Sale | -1,628 | -0.85%191,014 | $3.74 | $6,095 | View SEC filing | |
| 2023-04-27 | Stein Robert Benjamin President, Regenerative Med. | Sale | -5,987 | -1.51%389,400 | $3.74 | $22,415 | View SEC filing | |
| 2023-04-27 | Carlson Peter M Chief Financial Officer | Sale | -6,094 | -0.91%662,411 | $3.74 | $22,816 | View SEC filing | |
| 2023-04-13 | Hulse William Frank IV General Counsel and CAO | Sale | -5,995 | -1.26%468,422 | $3.31 | $19,843 | View SEC filing |
1-25 of 135
